As part of a “ground-breaking” procurement deal between National Health Service England and Gilead, AbbVie and MSD, the three drug companies will provide their hepatitis C treatments and help find as yet diagnosed hepatitis C patients.
The deal is part of NHS England’s ambitious plan to eliminate hepatitis C in England by 2025, five years earlier...








